KalVista Pharmaceuticals, Inc. (KALV)
USD 8.46
(-2.2%)
USD 8.46
(-2.2%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 12.69 Million | 12.69 Million | 16.12 Million |
| Cost of Revenue | 86.16 Million | 802 Thousand | 743 Thousand | 651 Thousand | 40.19 Thousand | 35.02 Thousand |
| Gross Profit | -86.16 Million | -802 Thousand | -743 Thousand | 12.03 Million | 12.64 Million | 16.09 Million |
| Operating Expenses | 54.27 Million | 110.87 Million | 96.61 Million | 57.92 Million | 53.22 Million | 45.94 Million |
| Selling, General and Administrative Expenses | 54.27 Million | 30.59 Million | 26.44 Million | 16.63 Million | 13.02 Million | 10.92 Million |
| Research and Development Expenses | 86.16 Million | 80.27 Million | 70.16 Million | 41.28 Million | 40.19 Million | 35.02 Million |
| Other Expenses | -86.16 Million | 15.64 Million | 14.72 Million | 9.92 Million | 9.83 Million | 7.68 Million |
| Cost and Expenses | 140.44 Million | 110.87 Million | 96.61 Million | 57.92 Million | 53.22 Million | 45.94 Million |
| Operating Income | -140.44 Million | -110.87 Million | -96.61 Million | -57.92 Million | -40.53 Million | -29.82 Million |
| Interest Expense | - | - | 1.09 Million | - | - | - |
| Income Tax Expense | -8.45 Million | -18.05 Million | -13.82 Million | -1.75 Million | -124 Thousand | 124 Thousand |
| Earnings before Tax | -135.09 Million | -92.9 Million | -82.33 Million | -46.24 Million | -29.24 Million | -20.69 Million |
| Net Income | -126.64 Million | -74.85 Million | -68.51 Million | -44.49 Million | -29.11 Million | -20.81 Million |
| Earnings Per Share Basic | -3.44 | -2.68 | -2.80 | -2.33 | -1.64 | -1.38 |
| Earnings Per Share Diluted | -3.44 | -2.68 | -2.80 | -2.33 | -1.64 | -1.38 |
| Weighted Average Shares Outstanding | 36.78 Million | 27.89 Million | 24.47 Million | 19.09 Million | 17.74 Million | 15.08 Million |
| Weighted Average Shares Outstanding (Diluted) | 36.78 Million | 27.89 Million | 24.47 Million | 19.09 Million | 17.74 Million | 15.08 Million |
| Gross Margin | - | - | - | 0.95 | 1.00 | 1.00 |
| EBIT Margin | - | - | - | -4.59 | -3.12 | -1.83 |
| Profit Margin | - | - | - | -3.51 | -2.29 | -1.29 |
| EBITDA | -134.28 Million | -92.1 Million | -81.59 Million | -45.59 Million | -40.02 Million | -29.44 Million |
| Earnings Before Tax Margin | - | - | - | -4.56 | -3.19 | -1.85 |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 1.2 Million | - | - | - | - | - |
| Cost of Revenue | 219 Thousand | 816 Thousand | 207 Thousand | 197 Thousand | 199 Thousand | 324 Thousand |
| Gross Profit | 987 Thousand | -816 Thousand | -207 Thousand | -197 Thousand | -199 Thousand | -324 Thousand |
| Operating Expenses | 48.23 Million | 148.08 Million | 32.94 Million | 29.74 Million | 29.09 Million | 31.72 Million |
| Selling, General and Administrative Expenses | 22.98 Million | - | 10.42 Million | 10.65 Million | 9.78 Million | 7.77 Million |
| Research and Development Expenses | 25.24 Million | - | 22.52 Million | 19.08 Million | 19.3 Million | 23.95 Million |
| Other Expenses | -7.34 Million | - | 2.31 Million | 2.61 Million | 2.39 Million | 4.28 Million |
| Cost and Expenses | 48.45 Million | 148.89 Million | 33.15 Million | 29.74 Million | 29.09 Million | 31.72 Million |
| Operating Income | -48.45 Million | -148.89 Million | -33.15 Million | -29.74 Million | -29.09 Million | -31.72 Million |
| Interest Expense | - | - | - | - | - | -1.42 Million |
| Income Tax Expense | 856 Thousand | -8.45 Million | - | 523 Thousand | -1.37 Million | 13.72 Million |
| Earnings before Tax | -44.65 Million | -135.09 Million | -29.02 Million | -27.65 Million | -25.31 Million | -26.3 Million |
| Net Income | -44.65 Million | -126.64 Million | -29.02 Million | -27.65 Million | -25.31 Million | -40.03 Million |
| Earnings Per Share Basic | -1.02 | - | -0.84 | -0.80 | -0.74 | -1.17 |
| Earnings Per Share Diluted | -1.02 | - | -0.84 | -0.80 | -0.74 | -1.17 |
| Weighted Average Shares Outstanding | 43.59 Million | 36.78 Million | 34.72 Million | 34.56 Million | 34.41 Million | 34.34 Million |
| Weighted Average Shares Outstanding (Diluted) | 43.59 Million | 36.78 Million | 34.72 Million | 34.56 Million | 34.41 Million | 34.34 Million |
| Gross Margin | 0.82 | - | - | - | - | - |
| EBIT Margin | -40.00 | - | - | - | - | - |
| Profit Margin | -37.02 | - | - | - | - | - |
| EBITDA | -48.23 Million | - | -32.94 Million | -28.25 Million | -29.35 Million | -31.86 Million |
| Earnings Before Tax Margin | -40.18 | - | - | - | - | - |
6973
NTAR
6882
600704
0NFS
600176